Artal Group’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
2023
Q3
$3.98M Hold
2023
Q2
$5.63M Hold
2023
Q1
$4.33M Hold
2022
Q4
$5.8M Sell
2022
Q3
$13.7M Hold
2022
Q2
$6.11M Hold
2022
Q1
$9.13M Hold
2021
Q4
$14.7M Hold
2021
Q3
$18.8M Sell
2021
Q2
$30.1M Buy